ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,395
0,00%
Bitcoin
69 437,84
0,15%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Vir Biotechnology Inc (VIR)

  7. Vir Biotechnology Inc (VIR) Actualités

VIR Vir Biotechnology Inc

11,23
-0,75 (-6,26%)
07 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Vir Biotechnology Inc VIR NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,75 -6,26% 11,23 23:23:32
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
11,76 11,015 11,83 11,23 11,98
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
05/6/202412:04EDGAR2Form 8-K - Current report
05/6/202411:30BWTobevibart Monotherapy and Combination Therapy with..
03/6/202418:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202417:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/5/202420:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202420:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/5/202422:06EDGAR2Form 8-K - Current report
29/5/202422:05BWVir Biotechnology to Participate in the Goldman Sachs 45th..
29/5/202414:05BWVir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as..
23/5/202422:05BWVir Biotechnology to Host 2024 Annual Meeting of..
22/5/202414:05BWMultiple Abstracts Highlighting Vir Biotechnology’s Latest..
21/5/202414:17BWVir Biotechnology Announces SOLSTICE Data to be Featured as..
14/5/202422:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
02/5/202422:05BWVir Biotechnology Provides Corporate Update and Reports..
30/4/202422:05BWVir Biotechnology to Participate in the BofA Securities..
18/4/202414:00BWVir Biotechnology Announces Nomination of Norbert..
11/4/202422:30BWVir Biotechnology to Provide Business Update and Report..
05/3/202414:05BWVir Biotechnology Completes Enrollment of Phase 2 Chronic..
27/2/202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202401:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202422:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23/2/202414:05BWVir Biotechnology to Participate in Upcoming Investor..
22/2/202422:12EDGAR2Form 8-K - Current report
22/2/202422:05BWVir Biotechnology Provides Corporate Update and Reports..
20/2/202422:33EDGAR2Form 8-K - Current report
20/2/202422:30BWVir Biotechnology Announces Dr. Phil Pang Will Step Down as..
17/2/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202422:05BWVir Biotechnology to Provide Business Update and Report..
03/1/202420:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202311:59IHMARKETNEWSApple Stocks Reach Record, Adobe Faces Stock Drops,..
13/12/202322:06EDGAR2Form 8-K - Current report
13/12/202322:05BWVir Biotechnology Announces Strategic Steps to Reduce..
06/12/202322:05BWVir Biotechnology to Present at J.P. Morgan 2024 42nd Annual..
13/11/202314:00BWVir Biotechnology to Present New Data from Its Ongoing Phase..
10/11/202314:00BWVir Biotechnology to Present Late-Breaking Data from Its..
08/11/202314:05BWVir Biotechnology Ranked the Fastest-Growing Company in..
03/11/202321:37EDGAR2Form 8-K - Current report
03/11/202321:33EDGAR2Form S-3ASR - Automatic shelf registration statement of..
03/11/202321:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:09EDGAR2Form 8-K - Current report
02/11/202321:05BWVir Biotechnology Provides Corporate Update and Reports..
30/10/202313:00BWVir Biotechnology Appoints Jennifer Towne, Ph.D., as..
12/10/202322:05GLOBEVir Biotechnology to Participate in the H.C. Wainwright 4th..
11/10/202314:00GLOBEVir Biotechnology Announces Multiple Abstracts Highlighting..
05/10/202322:30GLOBEVir Biotechnology to Provide Business Update and Report..
03/10/202314:01EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
VIR
Vir Biotechnology
USOTC
ORWHF
Oriental Watch (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés